Clinical Trial: Abuse Potential of Oral Gabapentin in Healthy, Non-Drug-Dependent Individuals With Recreational Sedative Drug Use Experience

U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07777965) titled 'Abuse Potential of Oral Gabapentin in Healthy, Non-Drug-Dependent Individuals With Recreational Sedative Drug Use Experience' on Aug. 17.

Brief Summary: The purpose of the present study is to assess prospectively the abuse potential of gabapentin compared to placebo and alprazolam in healthy non-drug-dependent recreational sedative drug users under fasted condition.

Study Start Date: June 18

Study Type: INTERVENTIONAL

Condition: Healthy Non-dependent, Recreational Sedative Users

Intervention: DRUG: Alprazolam (Xanax)

2mg

DRUG: Placebo

placebo

DRUG: Gabapentin (Neurontin(R) (Registered Trademark))

1200mg

DRUG: Gabapentin ...